{"id":"https://openalex.org/W3207771670","doi":"https://doi.org/10.1212/wnl.96.15_supplement.1300","title":"Effect of Ofatumumab on Serum Immunoglobulin Levels and Infection Risk in Relapsing Multiple Sclerosis (RMS) Patients from the Phase 3 ASCLEPIOS I and II Trials (1300)","display_name":"Effect of Ofatumumab on Serum Immunoglobulin Levels and Infection Risk in Relapsing Multiple Sclerosis (RMS) Patients from the Phase 3 ASCLEPIOS I and II Trials (1300)","publication_year":2021,"publication_date":"2021-04-13","ids":{"openalex":"https://openalex.org/W3207771670","doi":"https://doi.org/10.1212/wnl.96.15_supplement.1300","mag":"3207771670"},"language":"en","primary_location":{"id":"doi:10.1212/wnl.96.15_supplement.1300","doi":"https://doi.org/10.1212/wnl.96.15_supplement.1300","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.96.15_supplement.1300","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5077310868","display_name":"Amit Bar\u2010Or","orcid":"https://orcid.org/0000-0001-7179-0335","observed_orcids":["https://orcid.org/0000-0001-7179-0335","https://orcid.org/0000-0003-2931-1585"]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amit Bar-Or","raw_affiliation_strings":["University of Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pennsylvania","institution_ids":["https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011213325","display_name":"Jerome De Seze","orcid":"https://orcid.org/0000-0002-7197-7578","observed_orcids":["https://orcid.org/0000-0002-7197-7578"]},"institutions":[{"id":"https://openalex.org/I4210145324","display_name":"H\u00f4pitaux Universitaires de Strasbourg","ror":"https://ror.org/04bckew43","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210145324"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Jerome De Seze","raw_affiliation_strings":["University Hospital of Strasbourg"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Hospital of Strasbourg","institution_ids":["https://openalex.org/I4210145324"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047408530","display_name":"Jorge Daniel Correale","orcid":"https://orcid.org/0000-0003-4756-9889","observed_orcids":["https://orcid.org/0000-0003-4756-9889","https://orcid.org/0009-0002-4854-4763"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jorge Correale","raw_affiliation_strings":["Institute for Neurological Research Dr. Raul Carrea"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Neurological Research Dr. Raul Carrea","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Anne Cross","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I204465549","display_name":"Washington University in St. Louis","ror":"https://ror.org/01yc7t268","country_code":"US","type":"education","lineage":["https://openalex.org/I204465549"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anne Cross","raw_affiliation_strings":["Washington University School of Medicine"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Washington University School of Medicine","institution_ids":["https://openalex.org/I204465549"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054874316","display_name":"Ludwig Kappos","orcid":"https://orcid.org/0000-0003-4175-5509","observed_orcids":["https://orcid.org/0000-0003-4175-5509"]},"institutions":[{"id":"https://openalex.org/I1850255","display_name":"University of Basel","ror":"https://ror.org/02s6k3f65","country_code":"CH","type":"education","lineage":["https://openalex.org/I1850255"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Ludwig Kappos","raw_affiliation_strings":["University Hospital and University of Basel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Hospital and University of Basel","institution_ids":["https://openalex.org/I1850255"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034380106","display_name":"Krzysztof W. Selmaj","orcid":"https://orcid.org/0000-0003-1213-7218","observed_orcids":["https://orcid.org/0000-0003-1213-7218"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Krzysztof Selmaj","raw_affiliation_strings":["Center for Neurology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Neurology","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038373894","display_name":"Heinz Wiendl","orcid":"https://orcid.org/0000-0003-4310-3432","observed_orcids":["https://orcid.org/0000-0003-4310-3432","https://orcid.org/0000-0001-5509-1075"]},"institutions":[{"id":"https://openalex.org/I22465464","display_name":"University of M\u00fcnster","ror":"https://ror.org/00pd74e08","country_code":"DE","type":"education","lineage":["https://openalex.org/I22465464"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Heinz Wiendl","raw_affiliation_strings":["University of Muenster"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Muenster","institution_ids":["https://openalex.org/I22465464"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091387463","display_name":"C\u00e9cile Kerlo\u00ebguen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Cecile Kerloeguen","raw_affiliation_strings":["Novartis Pharma AG"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharma AG","institution_ids":["https://openalex.org/I1283582996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089098765","display_name":"Ratnakar Pingili","orcid":"https://orcid.org/0000-0002-4553-1871","observed_orcids":["https://orcid.org/0000-0002-4553-1871"]},"institutions":[{"id":"https://openalex.org/I4210117619","display_name":"Novartis (United States)","ror":"https://ror.org/028fhxy95","country_code":"US","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210117619"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ratnakar Pingili","raw_affiliation_strings":["Novartis Pharmaceuticals Corporation"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation","institution_ids":["https://openalex.org/I4210117619"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091482318","display_name":"Roseanne Sullivan","orcid":"https://orcid.org/0000-0001-6025-465X","observed_orcids":["https://orcid.org/0000-0001-6025-465X"]},"institutions":[{"id":"https://openalex.org/I4210117619","display_name":"Novartis (United States)","ror":"https://ror.org/028fhxy95","country_code":"US","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210117619"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Roseanne Sullivan","raw_affiliation_strings":["Novartis Pharmaceuticals Corporation"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation","institution_ids":["https://openalex.org/I4210117619"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040932304","display_name":"Ayan Das Gupta","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ayan Das Gupta","raw_affiliation_strings":["Novartis Healthcare Pvt. Ltd"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Healthcare Pvt. Ltd","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011281760","display_name":"Valentine Jehl","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Valentine Jehl","raw_affiliation_strings":["Novartis Pharma AG"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharma AG","institution_ids":["https://openalex.org/I1283582996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072651915","display_name":"Dieter Adrian H\u00e4ring","orcid":"https://orcid.org/0000-0001-5690-8710","observed_orcids":["https://orcid.org/0000-0001-5690-8710"]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Dieter Haering","raw_affiliation_strings":["Novartis Pharma AG"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharma AG","institution_ids":["https://openalex.org/I1283582996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107540380","display_name":"Martin Bernhard Merschhemke","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Martin Merschhemke","raw_affiliation_strings":["Novartis Pharma AG"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharma AG","institution_ids":["https://openalex.org/I1283582996"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5104805489","display_name":"Stephen L. Hauser","orcid":"https://orcid.org/0000-0002-4932-4001","observed_orcids":["https://orcid.org/0000-0002-4932-4001"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephen Hauser","raw_affiliation_strings":["Univ of Calif San Francisco, Dept of Neurology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Univ of Calif San Francisco, Dept of Neurology","institution_ids":["https://openalex.org/I180670191"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":8,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.3586,"has_fulltext":false,"cited_by_count":11,"citation_normalized_percentile":{"value":0.81792473,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":90,"max":96},"biblio":{"volume":"96","issue":"15_supplement","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11735","display_name":"Peripheral Neuropathies and Disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11725","display_name":"Immunodeficiency and Autoimmune Disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ofatumumab","display_name":"ofatumumab","score":1.0},{"id":"https://openalex.org/keywords/relapsing-multiple-sclerosis","display_name":"relapsing multiple sclerosis","score":0.9629999995231628},{"id":"https://openalex.org/keywords/serum-immunoglobulins","display_name":"serum immunoglobulins","score":0.9350000023841858},{"id":"https://openalex.org/keywords/igg","display_name":"IgG","score":0.8880000114440918},{"id":"https://openalex.org/keywords/igm","display_name":"IgM","score":1.0},{"id":"https://openalex.org/keywords/infection-risk","display_name":"infection risk","score":0.9919999837875366},{"id":"https://openalex.org/keywords/b-cell-depletion-therapy","display_name":"B-cell depletion therapy","score":0.5770000219345093}],"concepts":[{"id":"https://openalex.org/C2778714382","wikidata":"https://www.wikidata.org/wiki/Q410656","display_name":"Ofatumumab","level":4,"score":0.8989594578742981},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7466585040092468},{"id":"https://openalex.org/C2780640218","wikidata":"https://www.wikidata.org/wiki/Q8277","display_name":"Multiple sclerosis","level":2,"score":0.7210299968719482},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.48239338397979736},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.42579782009124756},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.42421188950538635},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.18224921822547913}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1212/wnl.96.15_supplement.1300","doi":"https://doi.org/10.1212/wnl.96.15_supplement.1300","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.96.15_supplement.1300","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4281682144","https://openalex.org/W4394599287","https://openalex.org/W4316670356","https://openalex.org/W7167336173","https://openalex.org/W4389411214","https://openalex.org/W4214570861","https://openalex.org/W4391476331","https://openalex.org/W7164197567","https://openalex.org/W4394600333","https://openalex.org/W4367306576"],"abstract_inverted_index":{"Objective:":[0],"To":[1],"determine":[2],"serum":[3,45,271],"immunoglobulin":[4],"(Ig)":[5],"levels":[6,12,47,94,117,146,154,166,194,273,283],"and":[7,13,68,72,101,103,149,155,176,179,185,206,208,217,289,299],"investigate":[8],"associations":[9],"between":[10,151],"IgG/IgM":[11,93,116,145,153],"infection":[14,156],"risk":[15],"in":[16,33,36,44,115,234,270,312,331,349,367,386,404,422,441,459,484,508,532,557,627,652,677,702,727,752,777,801,819,837,855,873,891,915,939,963,987,1045,1063,1081,1100,1118,1136,1155,1179,1204,1228,1471,1489,1507,1525,1544,1562,1580,1598,1625,1649,1673,1698,1722,1746,1955,1979,2003,2027,2052],"ofatumumab-treated":[17],"patients.":[18],"Background:":[19],"Ofatumumab,":[20],"the":[21,56,123,140,313,332,350,368,387,405,423,442,460,485,509,533,558,628,653,678,703,728,753,778,802,820,838,856,874,892,916,940,964,988,1046,1064,1082,1101,1119,1137,1156,1180,1205,1229,1472,1490,1508,1526,1545,1563,1581,1599,1626,1650,1674,1699,1723,1747,1956,1980,2004,2028,2053,2065],"first":[22],"fully":[23],"human":[24],"anti-CD20":[25,52],"monoclonal":[26],"antibody,":[27],"demonstrated":[28],"superior":[29],"efficacy":[30],"versus":[31],"teriflunomide":[32,80,183,212,255,290],"RMS":[34],"patients":[35,59,143,163,190],"Phase":[37],"3":[38,239],"ASCLEPIOS":[39,57,174],"I/II":[40],"trials.":[41],"A":[42,112,268],"decline":[43,114],"Ig":[46],"was":[48,118,197,276,293],"observed":[49,278],"with":[50,144,169,200,211,228,279,286,297,2082,2103],"other":[51],"therapies.":[53],"Design/Methods:":[54],"In":[55],"trials,":[58],"received":[60,309,328,346,364,383,401,419,438,456,481,505,529,554,581,592,603,614,624,649,674,699,724,749,774,798,816,834,852,870,888,912,936,960,984,1011,1022,1033,1042,1060,1078,1097,1115,1133,1152,1176,1201,1225,1247,1255,1274,1285,1296,1307,1318,1329,1340,1352,1363,1374,1385,1396,1407,1419,1430,1441,1468,1486,1504,1522,1541,1559,1577,1595,1622,1646,1670,1695,1719,1743,1770,1781,1792,1803,1815,1824,1837,1850,1861,1872,1885,1899,1918,1933,1952,1976,2000,2024,2049],"subcutaneous":[61],"ofatumumab":[62,170,201,288],"20mg":[63],"on":[64,254,466,491,515,539,564,634,659,684,709,734,759,784,898,922,946,970,994,1162,1186,1211,1235,1605,1632,1656,1680,1705,1729,1753,1962,1986,2010,2034],"Days":[65],"1,":[66],"7,":[67],"14,":[69],"Week":[70,160,220],"4,":[71],"every":[73,104],"4":[74,100],"weeks":[75,106],"thereafter":[76,107],"or":[77,182,470,495,519,543,568,638,663,688,713,738,763,788,902,926,950,974,998,1166,1190,1215,1262,1609,1636,1660,1684,1709,1733,1757,1852,1863,1901,1966,1990,2014,2038,2062,2090,2111],"once-daily":[78],"oral":[79],"14mg":[81],"for":[82,317,322,336,341,354,359,372,377,391,396,409,414,427,432,446,451,464,475,489,500,513,524,537,548,562,573,632,643,657,668,682,693,707,718,732,743,757,768,782,793,806,811,824,829,842,847,860,865,878,883,896,907,920,931,944,955,968,979,992,1003,1050,1055,1068,1073,1086,1091,1105,1110,1123,1128,1141,1146,1160,1171,1184,1195,1209,1220,1233,1239,1476,1481,1494,1499,1512,1517,1530,1535,1549,1554,1567,1572,1585,1590,1603,1614,1630,1641,1654,1665,1678,1689,1703,1714,1727,1738,1751,1762,1827,1840,1875,1888,1921,1936,1960,1971,1984,1995,2008,2019,2032,2043,2057,2069],"up":[83],"to":[84,1265,1463,1913,1947,2087,2108],"30":[85],"months":[86],"(average":[87],"follow-up":[88],"duration:":[89],"18":[90],"months).":[91],"Serum":[92],"were":[95],"monitored":[96],"at":[97,129,219,247,262],"baseline,":[98],"Weeks":[99],"12,":[102],"12":[105],"(ofatumumab,":[108],"n=946;":[109],"teriflunomide,":[110],"n=936).":[111],"notable":[113],"defined":[119],"as":[120,319,338,356,374,393,411,429,448,808,826,844,862,880,1052,1070,1088,1107,1125,1143,1478,1496,1514,1532,1551,1569,1587,1829,1842,1877,1890,1923,1938,2059,2077,2098],"50%":[121],"of":[122,126,142,189,249,264,302,315,334,352,370,389,407,425,444,462,487,511,535,560,577,588,599,610,630,655,680,705,730,755,780,804,822,840,858,876,894,918,942,966,990,1007,1018,1029,1048,1066,1084,1103,1121,1139,1158,1182,1207,1231,1243,1270,1281,1292,1303,1314,1325,1336,1348,1359,1370,1381,1392,1403,1415,1426,1437,1474,1492,1510,1528,1547,1565,1583,1601,1628,1652,1676,1701,1725,1749,1766,1777,1788,1799,1811,1832,1845,1880,1893,1926,1941,1958,1982,2006,2030,2055,2064,2067],"lower":[124],"limit":[125],"normal":[127],"(LLN)":[128],"any":[130],"time":[131,248,263],"(IgG,":[132],"3.5":[133],"g/L;":[134],"IgM,":[135],"0.2":[136],"g/L).":[137],"Outcomes":[138],"included":[139],"proportion":[141,188],"<50%":[147,167,195,274],"LLN,":[148],"association":[150,296],"low":[152],"incidence.":[157],"Results:":[158],"At":[159],"120,":[161],"no":[162,294],"reached":[164,192],"IgG":[165,172,272],"LLN":[168,196,275],"(median":[171,202,213],"[g/L]:":[173,204,215],"I":[175],"II,":[177],"10.57":[178],"9.57,":[180],"respectively)":[181],"(10.01":[184],"9.65).":[186],"The":[187,575,586,597,608,1005,1016,1027,1241,1268,1279,1290,1301,1312,1323,1334,1346,1357,1368,1379,1390,1401,1413,1424,1435,1764,1775,1786,1797,1809],"who":[191,256],"IgM":[193,203,214,282],"2.1%":[198],"(n=20/944)":[199],"0.91":[205],"0.59)":[207],"0.6%":[209],"(n=6/933)":[210],"0.84":[216],"0.92)":[218],"120.":[221],"Of":[222],"these":[223],"patients,":[224],"five":[225],"experienced":[226,257],"infections":[227,245],"ofatumumab,":[229],"mostly":[230],"non-serious":[231],"(Grade":[232],"1/2":[233],"severity),":[235],"except":[236],"one":[237],"Grade":[238],"recurrent":[240],"urinary":[241],"tract":[242],"infection.":[243],"All":[244],"resolved":[246],"last":[250,265],"follow-up.":[251,266],"One":[252],"patient":[253],"nasopharyngitis":[258],"had":[259],"not":[260,277],"recovered":[261],"Conclusions:":[267],"reduction":[269],"either":[280],"treatment.":[281],"showed":[284],"reductions":[285],"both":[287],"treatments;":[291],"there":[292],"apparent":[295],"treatment":[298],"increased":[300],"rate":[301],"serious/non-serious":[303],"infections.":[304],"Disclosure:":[305],"Dr.":[306,325,343,361,380,398,416,435,453,478,502,526,551,578,589,600,611,795,813,831,849,867,885,909,933,957,981,1008,1019,1030,1039,1057,1075,1094,1112,1130,1149,1173,1198,1222,1244,1252,1271,1282,1293,1304,1315,1326,1337,1349,1360,1371,1382,1393,1404,1416,1427,1438,1465,1483,1501,1519,1538,1556,1574,1592,1619,1643,1667,1692,1716,1740,1767,1778,1789,1800,1812,1949,1973,1997,2021,2046,2071,2092],"Bar-Or":[307,326,344,362,381,399,417,436,454,479,503,527,552,579,590,601,612],"has":[308,327,345,363,382,400,418,437,455,480,504,528,553,580,591,602,613,623,648,673,698,723,748,773,797,815,833,851,869,887,911,935,959,983,1010,1021,1032,1041,1059,1077,1096,1114,1132,1151,1175,1200,1224,1246,1254,1273,1284,1295,1306,1317,1328,1339,1351,1362,1373,1384,1395,1406,1418,1429,1440,1461,1467,1485,1503,1521,1540,1558,1576,1594,1621,1645,1669,1694,1718,1742,1769,1780,1791,1802,1814,1823,1836,1849,1860,1871,1884,1898,1911,1917,1932,1945,1951,1975,1999,2023,2048,2073,2094],"personal":[310,329,347,365,384,402,420,439,457,482,506,530,555,625,650,675,700,725,750,775,799,817,835,853,871,889,913,937,961,985,1043,1061,1079,1098,1116,1134,1153,1177,1202,1226,1469,1487,1505,1523,1542,1560,1578,1596,1623,1647,1671,1696,1720,1744,1825,1838,1873,1886,1919,1934,1953,1977,2001,2025,2050],"compensation":[311,330,348,366,385,403,421,440,458,483,507,531,556,626,651,676,701,726,751,776,800,818,836,854,872,890,914,938,962,986,1044,1062,1080,1099,1117,1135,1154,1178,1203,1227,1470,1488,1506,1524,1543,1561,1579,1597,1624,1648,1672,1697,1721,1745,1826,1839,1874,1887,1920,1935,1954,1978,2002,2026,2051],"range":[314,333,351,369,388,406,424,443,461,486,510,534,559,629,654,679,704,729,754,779,803,821,839,857,875,893,917,941,965,989,1047,1065,1083,1102,1120,1138,1157,1181,1206,1230,1473,1491,1509,1527,1546,1564,1582,1600,1627,1651,1675,1700,1724,1748,1957,1981,2005,2029,2054],"$500-$4,999":[316,335,353,371,390,408,426,445,463,488,512,536,561,631,656,681,706,731,756,781,805,823,841,859,877,895,919,943,967,991,1049,1085,1140,1511,1529],"serving":[318,337,355,373,392,410,428,447,465,490,514,538,563,633,658,683,708,733,758,783,807,825,843,861,879,897,921,945,969,993,1051,1069,1087,1106,1124,1142,1161,1185,1210,1234,1477,1495,1513,1531,1550,1568,1586,1604,1631,1655,1679,1704,1728,1752,1828,1841,1876,1889,1922,1937,1961,1985,2009,2033,2058],"a":[320,339,357,375,394,412,430,449,467,492,516,540,565,635,660,685,710,735,760,785,809,827,845,863,881,899,923,947,971,995,1053,1071,1089,1108,1126,1144,1163,1187,1212,1236,1260,1479,1497,1515,1533,1552,1570,1588,1606,1633,1657,1681,1706,1730,1754,1963,1987,2011,2035,2074,2078,2095,2099],"Consultant":[321,340,358,376,395,413,431,450,810,828,846,864,882,1054,1072,1090,1109,1127,1145,1480,1498,1516,1534,1553,1571,1589],"Roche":[323,1454,2083],"Genentech.":[324,1111,1172,1240,1251,1311],"Novartis.":[342,525,585,866,980,1129,1221,1367,1555,1715,1796,1833,1846,1857,1881,1942],"Janssen/Actelion.":[360],"Atara":[378,476],"Biotherapeutics.":[379,477],"Biogen.":[397,596,848,956,1026,1056,1289,1500,1642,1774],"BMS.":[415],"Merk/EMD":[433],"Serono.":[434,550,619,1093,1197,1345,1537,1691],"Sanofi-Genzyme.":[452,884,1004],"Scientific":[468,493,517,541,566,636,661,686,711,736,761,786,900,924,948,972,996,1164,1188,1213,1607,1634,1658,1682,1707,1731,1755,1964,1988,2012,2036],"Advisory":[469,494,518,542,567,637,662,687,712,737,762,787,901,925,949,973,997,1165,1189,1214,1608,1635,1659,1683,1708,1732,1756,1965,1989,2013,2037],"Data":[471,496,520,544,569,639,664,689,714,739,764,789,903,927,951,975,999,1167,1191,1216,1610,1637,1661,1685,1710,1734,1758,1967,1991,2015,2039],"Safety":[472,497,521,545,570,640,665,690,715,740,765,790,904,928,952,976,1000,1168,1192,1217,1611,1638,1662,1686,1711,1735,1759,1968,1992,2016,2040],"Monitoring":[473,498,522,546,571,641,666,691,716,741,766,791,905,929,953,977,1001,1169,1193,1218,1612,1639,1663,1687,1712,1736,1760,1969,1993,2017,2041],"board":[474,499,523,547,572,642,667,692,717,742,767,792,906,930,954,978,1002,1170,1194,1219,1613,1640,1664,1688,1713,1737,1761,1970,1994,2018,2042],"Roche/Genentech.":[501,607],"Merck/EMD":[549,618],"Sanofi/Genzyme.":[574],"institution":[576,587,598,609,1006,1017,1028,1242,1269,1280,1291,1302,1313,1324,1335,1347,1358,1369,1380,1391,1402,1414,1425,1436,1765,1776,1787,1798,1810],"research":[582,593,604,615,1012,1023,1034,1248,1275,1286,1297,1308,1319,1330,1341,1353,1364,1375,1386,1397,1408,1420,1431,1442,1771,1782,1793,1804,1816],"support":[583,594,605,616,1013,1024,1035,1249,1276,1287,1298,1309,1320,1331,1342,1354,1365,1376,1387,1398,1409,1421,1432,1443,1772,1783,1794,1805,1817],"from":[584,595,606,617,1014,1025,1036,1250,1259,1277,1288,1299,1310,1321,1332,1343,1355,1366,1377,1388,1399,1410,1422,1433,1444,1773,1784,1795,1806,1818,1856,1867,1905],"Jerome":[620,645,670,695,720,745,770],"De":[621,646,671,696,721,746,771],"Seze":[622,647,672,697,722,747,772],"Pharma.":[644,669,694,719,744,769,794],"Correale":[796,814,832,850,868,886,910,934,958,982,1009,1020,1031],"Roche.":[812,1378,1573,1739],"Merck.":[830,932,1015,1785],"ROche.":[908],"Novartis":[1037,1894,1906,1927,2104],".":[1038],"Cross":[1040,1058,1076,1095,1113,1131,1150,1174,1199,1223,1245,1253],"$5,000-$9,999":[1067,1104,1122,1159,1183,1208,1232,1475,1602,1629,1677,1702],"Celgene.":[1074,1300],"EMD":[1092,1196,1536],"TG":[1147,1411],"Therapeutics.":[1148,1412],"Speakers":[1237],"Bureau":[1238],"intellectual":[1256],"property":[1257],"interests":[1258,2089,2110],"discovery":[1261],"technology":[1263],"relating":[1264],"health":[1266],"care.":[1267],"Kappos":[1272,1283,1294,1305,1316,1327,1338,1350,1361,1372,1383,1394,1405,1417,1428,1439],"Bayer.":[1278],"Gemzyme.":[1322],"Janssen.":[1333],"Merck":[1344,1690],"Minoryx.":[1356],"Sanofi.":[1389],"Santhera.":[1400],"Abbvie.":[1423],"Eisai.":[1434],"Swiss":[1445,1448],"MS":[1446],"Society,":[1447],"National":[1449],"Research":[1450,1455],"Foundation,":[1451,1456],"European":[1452],"Union,":[1453],"Innosuisse.":[1457],"Krzysztof":[1458],"W.":[1459],"Selmaj":[1460],"nothing":[1462,1912,1946],"disclose.":[1464,1914,1948],"Wiendl":[1466,1484,1502,1520,1539,1557,1575,1593,1620,1644,1668,1693,1717,1741,1768,1779,1790,1801,1813],"Actelion.":[1482],"$10,000-$49,999":[1493,1548,1566,1584,1653,1726,1750],"Bristows.":[1518],"Sanofi-Aventis.":[1591,1763],"PSI":[1615],"CRO":[1616],"Deutschland":[1617],"GmbH.":[1618],"Genzyme.":[1666],"Hoffmann":[1807],"LaRoche.":[1808],"Deutsche":[1819],"Forschungsgemeinschaft.":[1820],"Cecile":[1821,1834,1847,1858],"Kerloeguen":[1822,1835,1848,1859],"an":[1830,1843,1853,1864,1878,1891,1902,1924,1939,2060],"employee":[1831,1844,1879,1892,1925,1940],"stock":[1851,1862,1900],"ownership":[1854,1865,1903],"interest":[1855,1866,1904],"novartis.":[1868],"Ratnakar":[1869],"Pingili":[1870],"Roseanne":[1882,1896],"Sullivan":[1883,1897],"Pharmaceuticals.":[1895,1907],"AYAN":[1908],"DAS":[1909],"GUPTA":[1910],"Valentine":[1915],"Jehl":[1916],"Pharma":[1928],"AG.":[1929],"Dieter":[1930],"Haering":[1931],"Martin":[1943],"Merschhemke":[1944],"Hauser":[1950,1974,1998,2022,2047,2072,2093],"$0-$499":[1959,1983,2007,2031,2056],"Accure.":[1972],"Alector.":[1996],"Annexon.":[2020],"Molecular":[2044],"Stethoscope.":[2045],"officer":[2061],"member":[2063],"Board":[2066],"Directors":[2068],"Neurona.":[2070],"non-compensated":[2075,2096],"relationship":[2076,2097],"Clinical":[2079,2100],"Trial/Primary":[2080,2101],"Investigator":[2081,2102],"that":[2084,2105],"is":[2085,2106],"relevant":[2086,2107],"AAN":[2088,2109],"activities.":[2091,2112]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2021-10-25T00:00:00"}